Brief: LumiraDx Reports Fourth Quarter And Full Year 2021 Results
10/03/2022 11:06
March 10 (Reuters) - LumiraDx Ltd LMDX.O :
* LUMIRADX REPORTS FOURTH QUARTER AND FULL YEAR 2021 RESULTS
* Q4 LOSS PER SHARE $0.15
* Q4 REVENUE $118.3 MILLION VERSUS $112.3 MILLION
Source text for Eikon: ID:nPndlCT3a
Further company coverage: LMDX.O
Recent news on LumiraDx
See all newsBrief: LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9Th
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing